Greenwood Capital Associates LLC Jazz Pharmaceuticals PLC Transaction History

Greenwood Capital Associates LLC

  • $752 Million
  • Q4 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2019

May 03, 2019
SELL
$121.81 - $142.95 $479,687 - $562,937
-3,938 Closed
0 $0
Q4 2018

Feb 11, 2019
BUY
$115.94 - $166.74 $157,330 - $226,266
1,357 Added 52.58%
3,938 $488,000
Q3 2018

Nov 13, 2018
BUY
$161.01 - $180.57 $3,864 - $4,333
24 Added 0.94%
2,581 $434,000
Q2 2018

Aug 07, 2018
BUY
$146.33 - $183.18 $120,722 - $151,123
825 Added 47.63%
2,557 $441,000
Q1 2018

May 15, 2018
BUY
$135.59 - $157.16 $234,841 - $272,201
1,732 New
1,732 $262,000

Others Institutions Holding JAZZ

# of Institutions
542
Shares Held
59M
Call Options Held
125K
Put Options Held
58.4K
View Full List

About Jazz Pharmaceuticals plc

JAZZ Quotes by TradingView
  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $8.48B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Greenwood Capital Associates LLC Portfolio

Follow Greenwood Capital Associates LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenwood Capital Associates LLC, based on Form 13F filings with the SEC.

News

Stay updated on Greenwood Capital Associates LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email